ID: ALA365259

Max Phase: Preclinical

Molecular Formula: C25H26N2O6S

Molecular Weight: 482.56

Molecule Type: Small molecule

Representations

Canonical SMILES:  COc1cccc(C(=O)Nc2ccc(-c3ccc(S(=O)(=O)N[C@H](C(=O)O)C(C)C)cc3)cc2)c1

Standard InChI:  InChI=1S/C25H26N2O6S/c1-16(2)23(25(29)30)27-34(31,32)22-13-9-18(10-14-22)17-7-11-20(12-8-17)26-24(28)19-5-4-6-21(15-19)33-3/h4-16,23,27H,1-3H3,(H,26,28)(H,29,30)/t23-/m0/s1

Standard InChI Key:  OUCZIEVBEJQBJK-QHCPKHFHSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 482.56

Molecular Weight (Monoisotopic): 482.1512

AlogP: 4.00

#Rotatable Bonds: 9

Polar Surface Area: 121.80

Molecular Species: ACID

HBA: 5

HBD: 3

#RO5 Violations: 0

HBA (Lipinski): 8

HBD (Lipinski): 3

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 3.33

CX Basic pKa:

CX LogP: 4.32

CX LogD: 0.90

Aromatic Rings: 3

Heavy Atoms: 34

QED Weighted: 0.42

Np Likeness Score: -1.13

References

1. Wu J, Rush TS, Hotchandani R, Du X, Geck M, Collins E, Xu ZB, Skotnicki J, Levin JI, Lovering FE..  (2005)  Identification of potent and selective MMP-13 inhibitors.,  15  (18): [PMID:16005220] [10.1016/j.bmcl.2005.06.019]

Source

Source(1):

• Scientific Literature